Skip to content

Evaluation of performance characteristics and efficiency of the combination test of serum pepsinogen levels and Helicobacter pylori antibody in stomach cancer screening

Evaluation of performance characteristics and efficiency of the combination test of serum pepsinogen levels and Helicobacter pylori antibody in stomach cancer screening - Evaluation of performance characteristics and efficiency of the combination test of serum pepsinogen levels and Helicobacter pylori antibody in stomach cancer screening

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015434
Enrollment
5800
Registered
2014-10-15
Start date
2014-10-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach Cancer

Interventions

Screening of stomach cancer by X-ray Screening of stomach cancer by X-ray, serum pepsinogen and anti-Helicobacter pylori immunoglobulin G antibodies

Sponsors

Hachioji-city, Tokyo
Lead Sponsor
National Cancer Center, Japan Hachioji Medical Association
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Persons who get screening for stomach cancer between the age of 40 to 54

Exclusion criteria

Exclusion criteria: Persons with a previous history of stomach cancer Persons with a previous history of undergoing surgery on stomach cancer Persons undergoing treatment for upper gastrointestinal tract disease

Design outcomes

Primary

MeasureTime frame
Sensitivity and specificity of a barium meal X-ray examination for stomach cancer screening according to the risk level (Group A to D) classified by the blood test

Secondary

MeasureTime frame
Possible harms related to the new screening method, such as false positive, false negative and adverse effect due to H. pylori eradication therapy

Countries

Japan

Contacts

Public ContactTakeshi SHINDO

Hachioji City, tokyo Adult Medical Check-up Section

shindo_takeshi@city.hachioji.tokyo.jp042-620-7428

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026